Simulations Total Operating Expenses from 2010 to 2026
| SLP Stock | USD 12.44 0.11 0.89% |
Total Operating Expenses | First Reported 1996-11-30 | Previous Quarter 16.8 M | Current Value 10.2 M | Quarterly Volatility 8.4 M |
Macro event markers
Use the financial statements timeline for Simulations Plus to frame performance drivers and balance sheet structure. It connects Depreciation And Amortization of 9.9 M, Interest Expense of 0.0 or Total Revenue of 95.6 M and ratios such as Price To Sales Ratio of 5.9, Dividend Yield of 0.0072 or PTB Ratio of 2.49 with Simulations Plus Valuation and Volatility context.
Simulations | Total Operating Expenses | Build AI portfolio with Simulations Stock |
Evaluating Simulations Plus's Total Operating Expenses across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Simulations Plus's fundamental strength.
Latest Simulations Plus' Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Simulations Plus over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Simulations Plus' Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Simulations Plus' overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Simulations Total Operating Expenses Regression Statistics
| Arithmetic Mean | 35,760,814 | |
| Geometric Mean | 16,726,015 | |
| Coefficient Of Variation | 131.30 | |
| Mean Deviation | 34,129,124 | |
| Median | 14,296,000 | |
| Standard Deviation | 46,954,134 | |
| Sample Variance | 2204.7T | |
| Range | 139.8M | |
| R-Value | 0.81 | |
| Mean Square Error | 795.3T | |
| R-Squared | 0.66 | |
| Significance | 0.000071 | |
| Slope | 7,564,239 | |
| Total Sum of Squares | 35275.1T |
Simulations Total Operating Expenses History
Stock Overview, Methodology & Data Sources
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California. Simulations Plus is traded on NASDAQ Exchange in the United States. This overview emphasizes how Simulations Plus compares to peers on valuation quality and operating consistency. Current metrics include P/E of 75.17, P/B of 1.97, profit margin of -81.66%. Simulations Plus has a market cap of 250.62 M, P/E of 75.17, ROE of -41.21%.
Methodology
Unless otherwise specified, financial data for Simulations Plus is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Simulations (USA Stocks:SLP) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Simulations Plus is covered by 7 analysts. 3 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include RBC Capital Markets, Barclays, HSBC Global Research, Wells Fargo Securities, Bank of America Securities, Jefferies, Deutsche Bank, Stifel, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardPair Trading with Simulations Plus
Pair trading with Simulations Plus can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Moving together with Simulations Stock
| 0.83 | GLH | Global Health | PairCorr |
| 0.92 | DH | DeFinitive Healthcare | PairCorr |
| 0.78 | VSEE | VSee Health | PairCorr |
| 0.83 | EVH | Evolent Health | PairCorr |
Moving against Simulations Stock
| 0.37 | CHS | Comprehensive Healthcare Earnings Call Tomorrow | PairCorr |
The effectiveness of tax-loss harvesting on Simulations Plus depends on finding a suitable replacement asset. Instruments with correlation above 0.9 to Simulations Plus typically provide adequate market exposure during the required holding period.
Interpreting the correlation table for Simulations Plus: readings above 0.8 indicate strongly correlated pairs with minimal diversification benefit, while readings between -0.2 and +0.2 around Simulations Plus suggest near-independence and genuine portfolio diversification value.
Use Correlation analysis and pair trading evaluation for Simulations Plus to review hedging context. The view can be extended across sectors or other related groups.Additional Tools for Simulations Stock Analysis
| Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |